Differential expression of kinase genes in primary hyperparathyroidism: Adenoma versus normal and hyperplastic parathyroid tissue

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 1, 2007, Pages 126-130

  Schachter, Pinhas P ^a,c   Ayesh, Suhail ^b   Matouk, Imad ^b   Schneider, Tamar ^b   Czerniak, Abraham ^a   Hochberg, Abraham ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; DNA DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN P19; PROTEIN P21; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL GROWTH; COMPUTER PROGRAM; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMAGE ANALYSIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PARATHYROID HYPERPLASIA; PERIOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; THYROID ADENOMA; UPREGULATION;

ADENOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HYPERPARATHYROIDISM, PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARATHYROID NEOPLASMS; PHOSPHOTRANSFERASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33846599826     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Berger AC, Libutti SK, Bartlett DL, et al. Heterogenous gland size in sporadic multiple gland parathyroid hyperplasia. J Am Coll Surg. 1999;188:382-389.
2. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Nephrol Dial Transplant. 1999;14(suppl 1):63-65.
3. Arnold A, Staunton CE, Kim HC, et al. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med. 1988;318:658-662.
4. Heppner C, Kester MB, Agarwal SK, et al. Somatic mutations of the MEN1 gene in parathyroid tumours. Nat Genet. 1997;16:375-378.
5. Carling T, Correa P, Hedberg J, et al. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab. 1998;83:2960-2963.
6. Farnebo F, Teh BT, Kytölä S, et al. Alterations of the MEN1 gene in sporadic parathyroid tumours. J Clin Endocrinol Metab. 1998;83:2627-2630.
7. Hsi ED, Zuckerberg LR, Yang WI, et al. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab. 1996;81:1736-1739.
8. Hemmer S, Wasenius VM, Haglund C, et al. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol. 2001;158:1355-1362.
9. Vasef MA, Brynes RK, Sturm M, et al. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Modern Pathol. 1999;12:412-416.
10. Motokura T, Bloom T, Kim HC, et al. A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature. 1991;350:512-515.
11. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science. 1997;276:404-407.
12. Forsberg L, Bjorck E, Hashemi J, et al. Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. Eur J Endocrinol. 2005;152:459-470.
13. Velin AK, Herder A, Johansson KJ, et al. Telomerase is not activated in human hyperplastic and adenomatous parathyroid tissue. Eur J Endocrinol. 2001;145:161-164.
14. Uchino S, Noguchi S, Nagatomo M, et al. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men 1 gene mutation in MEN2A-associated hyperplasia. Biomed Pharmacother. 2000;54:100s-103s.
15. Tahara H, Smith AP, Gaz RD, et al. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res. 1996;56:599-605.
16. Palanisamy N, Imanishi Y, Rao PH, et al. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab. 1998;83:1766-1770.
17. Farnebo F, Kytölä S, Teh BT, et al. Alternative genetic pathways in parathyroid tumorigenesis. J Clin Endocrinol Metab. 1999;84:3775-3780.
18. Hunter T, Pines J. Cyclins and cancer, II: cyclin D and CDK inhibitors come of age. Cell. 1994;79:773-782.
19. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79:551-555.
20. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149-1163.
21. Pestell RG, Albanese C, Reutens AT, et al. The cyclins and cyclin-dependent kinase inhibitors in normal regulation of proliferation and differentiation. Endocrinol Rev. 1999;20:501-534.
22. Lloyd RV, Jin L, Qian X, et al. Aberrant p27 kip1 expression in endocrine and other tumours. Am J Pathol. 1997;150:401-407.
23. Erickson LA, Jin L, Wollan P, et al. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27kip1 protein. Am J Surg Pathol. 1999;23:288-295.
24. Franklin DS, Godfrey VL, O'Brien DA, et al. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol. 2000;20:6147-6158.
25. Buchwald PC, Akerstrom G, Westin G. Reduced p18(INK4c), P21(CIP1/WAF1), and p27(KIP1) mRNA levels in tumors of primary and secondary hyperparathyroidism. Clin Endocrinol. 2004;60:389-393.
26. Bullrich F, MacLachlan TK, Sang N, et al. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res. 1995;55:1189-1205.
27. Schachter PP, Ayesh S, Schneider T, et al. Expression of kinase genes in primary hyperparathyroidism: adenoma versus hyperplastic parathyroid tissue. Surgery. 2002;132:1094-1098.
28. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995;92:3566-3570.
29. De Meyts B, Wallach CT, Cristoffersen B, et al. Insulin-like growth factor-1 receptor. Structure, ligand binding mechanism, and signal transduction. Horm Res. 1994;42:152-159.
30. Schultz SJ, Fry AM, Sutterlin C, et al. Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans. Cell Growth Differ. 1994;5:625-635.
31. Velazquez-Fernandez D, Laurell C, Saqui-Salces M, et al. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism: primary parathyroid hyperplasia versus adenoma. World J Surg. 2006;30:705-713.
32. Braz JC, Gregory K, Pathak A, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004;10:248-254.
33. Stojadinovic A, Hoos A, Nissan A, et al. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003;34:54-64.
34. Rosen JE, Costouros NG, Lorang D, et al. Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas. Ann Surg Oncol. 2005;12:1-5.